Edition:
United States

Aldeyra Therapeutics Inc (ALDX.A)

ALDX.A on American Stock Exchange

5.41USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
498
52-wk High
$16.55
52-wk Low
$5.01

About

Aldeyra Therapeutics, Inc., formerly Aldexa Therapeutics, Inc., is a biotechnology company. The Company's principal activities include raising capital and research and development activities. The Company's segment is the identification and development of a treatment for diseases related to high levels of aldehydes. The Company... (more)

Overall

Beta: 0.51
Market Cap(Mil.): $144.88
Shares Outstanding(Mil.): 27.49
Dividend: --
Yield (%): --

Financials

  ALDX.A Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -1.96 -- --
ROI: -79.69 7.77 12.69
ROE: -80.57 8.27 17.17

Aldeyra's eye drug meets main goal in late-stage study, shares surge

Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

Mar 26 2019

Aldeyra's eye drug meets main goal in late-stage study, shares surge

March 26 Aldeyra Therapeutics Inc said on Tuesday its drug reproxalap to treat a form of allergic reaction to the eye met the main goal in a late-stage trial, sending shares up more than 60 percent.

Mar 26 2019

Earnings vs. Estimates